| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |